Table 4 Gender comparison of metabolic syndrome component prevalence
From: Metabolic syndrome and its predictors in an urban population in Kenya: A cross sectional study
Variable | Categories | Male (n = 255) No. (%) | Female (n = 273) No. (%) | p-value |
|---|---|---|---|---|
BMI (kg/m2) | <25.00 | 132 (51.8%) | 110 (40.3%) | 0.001 |
25.00–29.99 | 95 (37.3%) | 103 (37.7%) | ||
30.00–39.99 | 28 (11.0%) | 60 (22.0%) | ||
WC (cm) | <94 (M) OR <80 (F) | 157 (61.6%) | 77 (28.2%) | 0.000 |
≥94 (M) OR ≥80 (F) | 98 (38.4%) | 196 (71.8%) | ||
TGs (mmol/L) | <1.7 | 194 (76.1%) | 243 (89.0%) | 0.000 |
≥1.7 | 61 (23.9%) | 30 (11.0%) | ||
HDL-C (mmol/L) | ≥1(M) OR ≥1.3 (F) | 179 (70.2%) | 125 (45.8%) | 0.000 |
<1(M) OR <1.3 (F) | 76 (29.8%) | 148 (54.2%) | ||
BP (mmHg) | SBP < 130 OR DBP < 85 | 119 (46.7%) | 168 (61.5%) | 0.001 |
SBP ≥ 130 OR DBP ≥ 85 | 136 (53.3%) | 105 (38.5%) | ||
FPG (mmol/L) | <5.6 | 212 (83.1%) | 233 (85.3%) | 0.486 |
≥5.6 | 43 (16.9%) | 40 (14.7%) | ||
10 year CVD risk (%) | ≤10% | 228 (89.4%) | 273 (100.0%) | 0.000 |
>10% | 27 (10.6%) | 0 (0.0%) |